Calls

US Grants

All US Grants and funding opportunities from the United States. Your guide to the most important research and development grants in the US. At the moment there are various funding opportunities, such as NIH grants calls or BARDA, CARB-X or Dod CDMRP grants.

NIH

About National Institutes of Health (NIH)

The NIH has 6 Centres and 21 Institutes covering their own expertise in a specific disease area (for example: National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), or National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)). These institutes release many funding opportunities regarding multiple topics (therapies, medicines or diagnostics).

This is done via multiple different funding mechanisms using different codes, of which R01 and R21 are the most used. A part of these calls are also eligible for non US based applicants. The scope and targeted activities are described in the scope of each tender and differs per tender. The different funding mechanism define the duration, budget and deadlines for the tenders.

R01 Research project grant

Subsidy: $2,500,000

R21 Exploratory/Developmental Research Grant

Subsidy: $275,000

 

More about this grant or visit the NIH website for more information.


 

Other US grants

BARDA Broad Agency Announcement (BAA)

Subsidy: no max.

Scope: Support advanced development activities of medical countermeasures for influenza and other emerging respiratory viruses to be specified by BARDA. BARDA is also prioritizing broadly reactive immunotherapeutics, such as monoclonal antibodies, that will be effective in treating severely ill, hospitalized patients of all ages who are infected with influenza or other emerging infectious diseases.

More about this grant or visit the website 

 


CARB-X

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria. With up to US$500 million to invest, CARB-X funds the best science from around the world.

Project should focus on early development of new antibiotics, vaccines, rapid diagnostics and other products to prevent, diagnose and treat life-threatening bacterial infections.

More about this grant or Visit the CARB-X website

 


DoD – CDMRP

The Congressionally Directed Medical Research Programs (CDMRP) publishes funding opportunities for research in diverse biomedical programs. These programs put great emphasis on service members, veterans, family members, and the general public.

The main mission is to eradicate diseases and support military health and American people. An unique partnership and collaboration between the military, government, scientists, patients, and their family members allow the program to bring research funding which focuses on directly relevant to each disease, condition, or injury.

Who can apply?

  • All (inter)national organizations (e.g. academic institutions, biotechnology companies, foundations, Federal Government organization other than the DoD, and research institutes).
  • Dod related organizations (military center, lab).

Visit the CDMRP website

 


US Foundations

Bill & Melinda Gates Foundation (BMGF)

The Bill & Melinda Gates Foundation (BMGF) is focused on the areas of greatest need, on the ways in which they can do the most good.

The foundation is teaming up with partners around the world to take on some tough challenges: extreme poverty and poor health in developing countries, and the failures of America’s education system. The foundation focusses on specific issues, which are the biggest barriers that prevent people from making the most of their lives.

For each issue they fund innovative ideas that could help remove these barriers:

  • New techniques to help farmers in developing countries grow more food and earn more money
  • New tools to prevent and treat deadly diseases
  • New methods to help students and teachers in the classroom.

There are no open Grant Opportunities at this time.

More about this foundation or visit the Gates foundation website

 


The Michael J. Fox Foundation (MJFF)

Subsidy: $180,000

Scope: Movement disorder specialists (neurologists with subspecialty training in Parkinson’s disease and other movement disorders) serve as an important bridge between scientific advances in the lab and positive patient outcomes in the care setting.

While the demand for movement disorder specialists is increasing, not enough neurologists are receiving this vital training. To address this unmet need, the Michael J. Fox Foundation (MJFF), in collaboration with the Edmond J. Safra Foundation, introduced The Edmond J. Safra Fellowship in Movement Disorders. By funding academic centers to train new movement disorder clinician-researchers, this program aims to develop a network of highly trained specialists to be the next generation of leaders in Parkinson’s research and clinical care.

More about this foundation or visit the MJFF website

 


Alzheimer’s Drug Discovery Foundation (ADDF): Drug Development program

Subsidy: $50,000-100,000 for epidemiological analyses; up to $3,000,000 for clinical trials

Scope: The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.

Specifically, the Prevention Beyond the Pipeline program supports:

  • Studies Leveraging the Consortium of Cohorts for Alzheimer’s Prevention Action (CAPA);
  • Comparative Effectiveness Research;
  • Studies of Cognitive Decline and Cognitive Reserve.

More about this foundation or visit the ADDF website

 


Alzheimer’s Drug Discovery Foundation (ADDF): Program To Accelerate Clinical Trials (PACT)

Subsidy: up to $3,000,000

Scope: The goal of this program is to increase the number of innovative pharmacologic interventions tested in clinical studies for Alzheimer’s disease and related dementias. This includes novel, repurposed, and repositioned drugs as well as natural products. The ADDF is interested in small molecules and biologics (e.g. antibodies, peptides, gene therapies).

Specifically, the PACT program supports:

  1. Early-stage human clinical trials;
  2. Regulatory studies.

More about this foundation or visit the ADDF website

 


Alzheimer’s Drug Discovery Foundation (ADDF): Neuroimaging And CSF Biomarker Development Program

Subsidy: $600,000

Scope: The aim of this program is to develop biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias.

Specifically, this program focuses on:

  • Developing novel PET ligands for clinical use
  • Supporting novel CSF biomarkers
  • Validating established MRI approaches in larger cohorts

More about this foundation or visit the ADDF website

 


Alzheimer’s Drug Discovery Foundation (ADDF): Prevention Beyond The Pipeline

Subsidy: $50,000-100,000 for epidemiological analyses; up to $3,000,000 for clinical trials

Scope: The ADDF seeks to support comparative effectiveness research, prevention clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.

Specifically, the Prevention Beyond the Pipeline program supports:

  • Studies Leveraging the Consortium of Cohorts for Alzheimer’s Prevention Action (CAPA);
  • Comparative Effectiveness Research;
  • Studies of Cognitive Decline and Cognitive Reserve.

More about this foundation or visit the ADDF website

Catalyze Figure Ovals Lightgray
Newsletter

A must-have if you’re interested in getting your business to the next level